Gilead Sciences Inc (GILD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-1998 | 12-1997 | 09-1997 | 06-1997 | 03-1997 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,380 | -27,993 | -15,569 | -5,237 | -7,948 |
| Depreciation Amortization | 680 | 2,983 | 2,277 | 1,539 | 753 |
| Other Working Capital | -80 | 5,150 | 5,636 | 5,394 | 9,729 |
| Operating Cash Flow | $-6,780 | $-19,860 | $-7,656 | $1,696 | $2,534 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -840 | -3,861 | -3,111 | -2,665 | -1,786 |
| Other Investing Activity | 9,050 | -126,074 | -122,242 | -34,524 | -29,270 |
| Investing Cash Flow | $8,210 | $-129,935 | $-125,353 | $-37,189 | $-31,056 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 880 | 49,801 | 46,695 | 42,470 | 1,280 |
| Financing Cash Flow | $880 | $49,801 | $46,695 | $42,470 | $1,280 |
| Beginning Cash Position | 31,990 | 131,984 | 131,984 | 131,984 | 131,984 |
| End Cash Position | 34,310 | 31,990 | 45,670 | 138,961 | 104,742 |
| Net Cash Flow | $2,320 | $-99,994 | $-86,314 | $6,977 | $-27,242 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,780 | -19,860 | -7,656 | 1,696 | 2,534 |
| Free Cash Flow | -6,780 | -19,860 | -7,656 | 1,696 | 2,534 |